---

---

tags : Publication    crawled time : 22:00   

save search

---

Evolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®
Published: 2024-04-17 (Crawled : 22:00) - biospace.com/
EOLS | $11.48 -1.88% -1.92% 260K |

Health Technology

| -2.9% | O: -1.49% H: 0.0% C: 0.0%
jeuveau publication for study

---

New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalLack of early symptom improvement is not predictive of final responder status
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
STIM | $3.76 -2.59% -2.66% 21K |

Health Technology

| -8.75% | O: 1.18% H: 4.28% C: 1.17%
publication treatment

---

Merus Announces Publication of an Abstract for Presentation at the AACR Annual Meeting 2024: Zeno is effective in cancer models with high NRG1 expression
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
MRUS | $41.96 2.79% 2.72% 740K |

Health Technology

| -18.31% | O: 0.06% H: 1.66% C: -2.56%
presentation cancer publication meeting

---

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
Published: 2024-03-01 (Crawled : 22:00) - biospace.com/
AADI | $1.79 -2.72% -2.79% 110K |

Manufacturing

| -6.6% | O: 1.02% H: 0.0% C: 0.0%
fyarro bioscience publication treatment

---

Ecopetrol announces the dates for the publication of its fourth quarter 2023 and full year earnings report and conference call
Published: 2024-02-15 (Crawled : 22:00) - prnewswire.com
EC | $11.69 -0.34% 0.26% 980K |

Energy Minerals

| -0.85% | O: -0.08% H: 0.55% C: 0.34%
conference report year publication

---

ArcelorMittal announces the publication of its fourth quarter and full year 2023 sell-side analyst consensus figures
Published: 2024-02-05 (Crawled : 22:00) - globenewswire.com
MT | News | $25.2 0.04% 0.0% 1M |

Non-Energy Minerals

| -6.7% | O: 0.67% H: 1.1% C: 0.74%
year publication

---

Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine
Published: 2024-01-31 (Crawled : 22:00) - globenewswire.com
NTLA | $21.16 -1.72% -1.75% 860K |

Health Technology

| -9.61% | O: 0.88% H: 8.11% C: 5.12%
ntla-2002 positive publication therapeutics

---

Vanda Pharmaceuticals announces the publication of an article on The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial
Published: 2024-01-25 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 16.62% | O: -1.0% H: 0.84% C: 0.04%
VNDA | $4.57 -1.3% -1.31% 1.5M |

Health Technology

| 26.16% | O: 2.72% H: 0.53% C: 0.53%
publication pharmaceuticals trial diabetic

---

Textainer Announces Date Of Special Meeting And Publication Of Its Proxy Statement To Approve Acquisition By Stonepeak
Published: 2024-01-17 (Crawled : 22:00) - globenewswire.com
TGH | $49.99 0.0% 1.2M |

Finance

| 1.13% | O: 0.34% H: 0.2% C: 0.2%
publication acquisition meeting

---

BridgeBio Pharma Announces Publication of Positive Results from Phase 3 ATTRibute-CM Study of Acoramidis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in the New England Journal of Medicine
Published: 2024-01-10 (Crawled : 22:00) - globenewswire.com
BBIO | $25.02 -1.73% -1.76% 1.5M |

Health Technology

| -36.19% | O: -1.4% H: 0.08% C: -0.31%
pharma positive publication results study

---

Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Nine Month Periods Ended September 30, 2023
Published: 2023-12-11 (Crawled : 22:00) - prnewswire.com
ELLO | $14.93 -1.52% -0.87% 2.4K |

Utilities

| 9.22% | O: 0.86% H: 2.79% C: 2.79%
energy publication financial

---

Publication Relating to a Transparency Notification
Published: 2023-12-08 (Crawled : 22:00) - globenewswire.com
NYXH | $10.34 -5.31% -5.61% 18K |

n/a

| Email alert Add to watchlist
publication

---

Regal Rexnord Corporation Announces Publication Of Annual Sustainability Report
Published: 2023-12-05 (Crawled : 22:00) - prnewswire.com
RRX | News | $164.23 -1.54% 0.47% 380K |

Manufacturing

| 34.7% | O: 0.89% H: 2.62% C: -0.37%
GIC | $40.96 -0.82% 0.0% 57K |

Retail Trade

| 13.12% | O: 0.79% H: 0.73% C: -1.49%
report corporation publication

---

Publication of a transparency notification
Published: 2023-11-30 (Crawled : 22:00) - celyad.com
CYADY | $0.6 0% 3K |

n/a

| Email alert Add to watchlist
CLYYF | $0.4138 -2.36% -1.88% 0 |

n/a

| Email alert Add to watchlist
publication

---

Y-mAbs Announces Publication in Cancers Naxitamab-based chemo-immunotherapy significantly improves long-term outcomes when administered early during the course of treatment
Published: 2023-10-16 (Crawled : 22:00) - biospace.com/
YMAB | $15.26 -0.52% -0.52% 160K |

Health Technology

| 189.43% | O: 1.13% H: 6.53% C: 0.75%
publication treatment

---

Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Three and Six Month Periods Ended June 30, 2023
Published: 2023-08-24 (Crawled : 22:00) - prnewswire.com
ELLO | $14.93 -1.52% -0.87% 2.4K |

Utilities

| 1.61% | O: 0.74% H: 3.46% C: 3.46%
energy six publication financial

---

Alnylam Announces Publication of Phase 1 Study Results for Zilebesiran in the New England Journal of Medicine
Published: 2023-07-19 (Crawled : 22:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -11.96% | O: 0.88% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 390K |

Health Technology

| -29.92% | O: 0.74% H: 0.28% C: -2.21%
publication results study

---

Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate
Published: 2023-07-19 (Crawled : 22:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M |

Health Technology

| -27.37% | O: 0.28% H: 0.99% C: 0.28%
candidate vaccine publication group

---

Cyclo Therapeutics Announces Publication of Positive Data from Phase 2 Clinical Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
Published: 2023-06-29 (Crawled : 22:00) - biospace.com/
CYTH | $1.21 7.94% 21K |

Professional, Scientific, and T...

| -30.46% | O: 1.72% H: 9.6% C: -11.3%
trappsol disease positive publication treatment therapeutics study

---

DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers
Published: 2023-05-10 (Crawled : 22:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K |

Health Technology

| -58.79% | O: 14.55% H: 0.0% C: -2.12%
peanut publication trial

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---